Research study Program year 2023 Source: CMS Open Payments

Emphysema Progression Biomarker Study

Research payments

$969,788

452 payments

Through program year 2023, $969,788 in research payments was reported against Emphysema Progression Biomarker Study, across 452 payments.

Paid by (largest first): Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Pharma GmbH & Co.KG
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$25,633	2
2022	Research	$16,804	3
2021	Research	$371,461	92
2020	Research	$213,720	174
2019	Research	$342,168	181

Breakdown

Who paid Research payments · program years 2019–2023

Boehringer Ingelheim Pharmaceuticals, Inc. $937,284 81 payments
Boehringer Ingelheim Pharma GmbH & Co.KG $32,503 371 payments

Who received the money Research payments · program years 2019–2023

Los Angeles Biomedical Research Organisation paid for research $167,171 6 payments
The Regents of The University of California Organisation paid for research $115,604 9 payments
University Of Iowa Hosp & Clinics Teaching hospital · IA $105,072 24 payments
Baylor College Of Medicine Organisation paid for research $91,982 28 payments
Johns Hopkins University Organisation paid for research $67,287 34 payments
Lung Diagnostic Organisation paid for research $47,996 4 payments
John Hopkins University Organisation paid for research $46,768 1 payment
Regents Of The University Of California Organisation paid for research $46,370 17 payments
Brigham And Womens Hospital Teaching hospital · MA $34,903 27 payments
National Jewish Health Teaching hospital · CO $30,773 18 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.